|
Frequency of Different Vascular Access Types Used in Hemodialysis Centers of Gorgan, Iran (2020-21)
|
Pezhman Kharazm1    , Saeid Amirkhanlou2 , Fatemeh Kharazm3 , Roozbeh Cheraghali * 4 |
1- Assistant Professor of Vascular Surgery, Department of Surgery, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
2- Associate Professor of Nephrology, Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
3- General Physician, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
4- Vascular Surgeren, Assistant Professor, Golestan University of Medical Sciences, Gorgan, Iran. , dr.r.cheraghali@goums.ac.ir |
|
|
Abstract: (3341 Views) |
Background and Objective: Hemodialysis is an important replacement therapy for 70-90% of patients with end-stage renal disease (ESRD). Arteriovenous fistula (AVF) is the vascular access of choice in these patients due to its higher efficiency and lower risk of mortality compared to arteriovenous grafts. This study was conducted to determine the frequency of vascular access types used in hemodialysis centers of Gorgan, Iran.
Methods: This descriptive-analytical study was done on 200 hemodialysis patients (101 men and 99 women) at 5 Azar and Sayyad Shirazi hospitals in Gorgan, north of Iran, during April 2020 to July 2021. The subjects were selected by the census method. Information including age, sex, education level, duration of dialysis, the initial and current types of vascular access, site of vascular access, history of diabetes or hypertension, race, and history of smoking were recorded in a checklist.
Results: The mean age of women and men was 58.34±4.71 and 57.95±13.76 years, respectively. In addition, 61.5% of the patients were under 3 years old. The most commonly used vascular access to initiate dialysis was non-cuffed temporary catheters (69%) and AVF (24%). Smoking, ethnicity, diabetes, hypertension, and gender had no significant association with the type of vascular access used. In addition, there was no significant relationship between the duration of dialysis and the type of vascular access.
Conclusion: Considering the diversity of catheters and fistulas, it is necessary to emphasize that the use of AVF in patients undergoing dialysis for the first time and the timely placement of AVF in ESRD patients can improve the quality of life of the patients. It is also recommended to use jugular catheters instead of subclavian catheters when required.
|
|
Keywords: End Stage Renal Disease [MeSH], Hemodialysis [MeSH], Vascular Access Devices [MeSH], Arteriovenous Fistula [MeSH], Arteriovenous Grafts , Iran [MeSH]
Article ID: Vol24-21 |
|
|
Full-Text [PDF 377 kb]
(8921 Downloads)
|
|
Type of Study: Original Articles |
Subject:
Cardiovascular Surgery
|
|
|
|
|
|
|
| References |
1. Yang CY, Wang YF, Ho Y, Wu CH, Lee CY, Tarng DC. Hemodialysis vascular access care during the COVID-19 pandemic. J Chin Med Assoc. 2020 Jul; 83(7): 634-38. DOI: 10.1097/JCMA.0000000000000348 [ DOI] [ PubMed] 2. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013 Feb; 24(3): 465-73. DOI: 10.1681/ASN.2012070643 [ DOI] [ PubMed] 3. Khavanin Zadeh M, Mohammadipour S, Omrani Z. Correlation between CRP and early failure of arteriovenous fistula (AVF). Med J Islam Repub Iran. 2015 Jun; 29: 219. [ PubMed] 4. Khavanin Zadeh M, Omrani Z, Cheraghli R, Hashemaghaee M. ESR, CRP, and failure of Arterio-Venous Fistula (AVF). Med J Islam Repub Iran. 2021; 35(1): 936-39. DOI: 10.47176/mjiri.35.125 [ View at Publisher] [ DOI] 5. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int. 2003 Nov; 64(5): 1893-902. DOI: 10.1046/j.1523-1755.2003.00277.x [ DOI] [ PubMed] 6. Agarwal AK, Haddad NJ, Vachharajani TJ, Asif A. Innovations in vascular access for hemodialysis. Kidney Int. 2019 May; 95(5): 1053-63. DOI: 10.1016/j.kint.2018.11.046 [ DOI] [ PubMed] 7. Almasri J, Alsawas M, Mainou M, Mustafa RA, Wang Z, Woo K, et al. Outcomes of vascular access for hemodialysis: A systematic review and meta-analysis. J Vasc Surg. 2016 Jul; 64(1): 236-43. DOI: 10.1016/j.jvs.2016.01.053 [ DOI] [ PubMed] 8. Khavanin Zadeh M, Omrani Z, Shirali A, Najmi N, Mohammad Zade M, Fereshtehnejad S. [Determination of Prevalence and Survival of Various Types of Vascular Accesses in Patients With End Stage Renal Disease Under Chronic Hemodialysis, in Tehran during 2004]. RJMS. 2009; 15: 71-77. [ View at Publisher] 9. Rezapour M, Taran S, Balin Parast M, Khavanin Zadeh M. The impact of vascular diameter ratio on hemodialysis maturation time: Evidence from data mining approaches and thermodynamics law. Med J Islam Repub Iran. 2016; 30(1): 407-14. [ View at Publisher] 10. Shabankareh M, Bahtooei M, Mirzaei K. [Investigating the prevalence and longevity of vascular access in chronic hemodialysis patients of Bushehr province in 2007]. M.D Thesis. Bushehr University of Medical Sciences. 2007. [Persian] 11. Beladi Mousavi S, Hayati F, Nazari I, Zeraati A. [Comparison of Temporary Dialysis Catheter and A-V Fistula Use at the Time of Starting Chronic Hemodialysis among End-Stage Renal Diseases Patients]. Medical Journal of Mashhad University of Medical sciences. 2011; 54(2): 75-79. DOI: 10.22038/mjms.2011.5348 [Article in Persian] [ View at Publisher] [ DOI] 12. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001 Oct; 60(4): 1443-51. DOI: 10.1046/j.1523-1755.2001.00947.x [ DOI] [ PubMed] 13. Sequeira A, Naljayan M, Vachharajani TJ. Vascular Access Guidelines: Summary, Rationale, and Controversies. Tech Vasc Interv Radiol. 2017 Mar; 20(1): 2-8. DOI: 10.1053/j.tvir.2016.11.001 [ DOI] [ PubMed] 14. Hamdan Z, As'ad N, Sawalmeh O, Shraim M, Kukhon F. Vascular access types in hemodialysis patients in palestine and factors affecting their distribution: A cross-sectional study. Saudi J Kidney Dis Transpl. 2019 Jan-Feb; 30(1): 166-74. [ PubMed] 15. Musini VM, Tejani AM, Bassett K, Puil L, Wright JM. Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database Syst Rev. 2019 Jun; 6(6): CD000028. DOI: 10.1002/14651858.CD000028.pub3 [ DOI] [ PubMed] 16. Khavaninzade M, Cheraghali R. Using vessel loops in creating vascular access. J Vasc Access. 2022 Jul; 23(4): 672-73. DOI: 10.1177/11297298211006974 [ DOI] [ PubMed] 17. Viecelli AK, Lok CE. Hemodialysis vascular access in the elderly-getting it right. Kidney Int. 2019 Jan; 95(1): 38-49. DOI: 10.1016/j.kint.2018.09.016 [ DOI] [ PubMed] 18. Cheraghali R, Farshidmehr P. The Patency Rate of the Primary and Exchanged Femoral Haemodialysis Catheters. Malays J Med Sci. 2021 Aug; 28(4): 97-102. DOI: 10.21315/mjms2021.28.4.10 [ DOI] [ PubMed] |
|
| Send email to the article author |
|
|
|
Kharazm P, Amirkhanlou S, Kharazm F, Cheraghali R. Frequency of Different Vascular Access Types Used in Hemodialysis Centers of Gorgan, Iran (2020-21). J Gorgan Univ Med Sci 2022; 24 (2) :48-52 URL: http://goums.ac.ir/journal/article-1-4060-en.html
|
